465 related articles for article (PubMed ID: 15716206)
1. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?
Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H
Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206
[TBL] [Abstract][Full Text] [Related]
2. Re: Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pfluger H. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol 2005; 47: 393-7.
Gupta SK
Eur Urol; 2005 Sep; 48(3):534. PubMed ID: 15994004
[No Abstract] [Full Text] [Related]
3. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
Lai MC; Kuo YC; Kuo HC
Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
[TBL] [Abstract][Full Text] [Related]
4. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis.
Shao Y; Shen ZJ; Rui WB; Zhou WL
Urology; 2010 Mar; 75(3):547-50. PubMed ID: 20022087
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of maximal bladder capacity, 0.9% NaCl versus 0.2 M Kcl, for the diagnosis of interstitial cystitis: a prospective controlled study.
Daha LK; Riedl CR; Hohlbrugger G; Knoll M; Engelhardt PF; Pflüger H
J Urol; 2003 Sep; 170(3):807-9. PubMed ID: 12913704
[TBL] [Abstract][Full Text] [Related]
6. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.
Morales A; Emerson L; Nickel JC; Lundie M
J Urol; 1996 Jul; 156(1):45-8. PubMed ID: 8648835
[TBL] [Abstract][Full Text] [Related]
7. The potassium sensitivity test: a predictor of treatment response in interstitial cystitis.
Gupta SK; Pidcock L; Parr NJ
BJU Int; 2005 Nov; 96(7):1063-6. PubMed ID: 16225529
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravesical glycosaminoglycan substitution therapy on bladder pain syndrome/interstitial cystitis, bladder capacity and potassium sensitivity.
Daha LK; Riedl CR; Lazar D; Simak R; Pflüger H
Scand J Urol Nephrol; 2008; 42(4):369-72. PubMed ID: 19230170
[TBL] [Abstract][Full Text] [Related]
9. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis.
Parsons CL
Urology; 2005 Jan; 65(1):45-8. PubMed ID: 15667861
[TBL] [Abstract][Full Text] [Related]
10. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
11. Interstitial cystitis versus detrusor overactivity: a comparative, randomized, controlled study of cystometry using saline and 0.3 M potassium chloride.
Philip J; Willmott S; Irwin P
J Urol; 2006 Feb; 175(2):566-70; discussion 570-1. PubMed ID: 16406997
[TBL] [Abstract][Full Text] [Related]
12. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
13. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin.
Welk BK; Teichman JM
Urology; 2008 Jan; 71(1):67-70. PubMed ID: 18242367
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized controlled trial of cystometry using saline versus 0.3 M potassium chloride infusion in women with overactive bladder syndrome.
Philip J; Willmott S; Owen D; Samsudin C; Irwin PP
Neurourol Urodyn; 2007; 26(1):110-4. PubMed ID: 17009304
[TBL] [Abstract][Full Text] [Related]
15. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
[TBL] [Abstract][Full Text] [Related]
16. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome.
Nickel JC; Moldwin R; Lee S; Davis EL; Henry RA; Wyllie MG
BJU Int; 2009 Apr; 103(7):910-8. PubMed ID: 19021619
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of urinary and general symptoms and correlation with other clinical parameters in interstitial cystitis patients.
Porru D; Tinelli C; Gerardini M; Giliberto GL; Stancati S; Rovereto B
Neurourol Urodyn; 2005; 24(1):69-73. PubMed ID: 15573384
[TBL] [Abstract][Full Text] [Related]
18. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
Nickel JC; Hanno P; Kumar K; Thomas H
Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
[TBL] [Abstract][Full Text] [Related]
19. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
Peng CH; Kuo HC
Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
